Sheng-Xiao Zhang (Shengxiao Zhang)

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 20

Top Topics

Systematic Review

Systemic Lupus Erythematosus

Disease Activity

Top Venues

Rheumatology and therapy

Immunity, inflammation and disease

Journal of immunology research

Annals of the rheumatic diseases

This page only lists publications with an associated author ORCID identifier.

Publications

Qin-Yi Su, Jing Luo, Xin-Miao Wang, Jing-Kai Di, Yi-Xin Cao, Sheng-Xiao Zhang
Efficacy, safety and the lymphocyte subsets changes of low-dose IL-2 in patients with systemic lupus erythematosus: A systematic review and meta-analysis. Immunity, inflammation and disease 12 (1) (2024)
Qin-Yi Su, Jing Luo, Yan Zhang, Qian Li, Zhong-Qing Jiang, Zi-Rong Wen, Yu-Ying Wang, Mo-Ran Shi, Sheng-Xiao Zhang
Efficacy and safety of current therapies for difficult-to-treat rheumatoid arthritis: a systematic review and network meta-analysis. Journal of translational medicine 22 (1) (2024)
Qin-Yi Su, Heng-Yan Gao, Yue-Ru Duan, Jing Luo, Wei-Ze Wang, Xi-Chao Qiao, Sheng-Xiao Zhang
The immunologic role of IL-23 in psoriatic arthritis: a potential therapeutic target. Expert opinion on biological therapy (2024)
Qin-Yi Su, Hao-Nan Zhou, Guo-Mei Xia, Rui-Yuan Zhang, Hong-Yuan Tian, Chang Su, Yu-Xin Liu, He-Yi Zhang, Ting Cheng, Yue-Hong Huo, Qian Li, Sheng-Xiao Zhang
Efficacy and Safety of Risankizumab in Patients with Psoriatic Arthritis: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Rheumatology and therapy 11 (2) (2024)
Qin-Yi Su, Liu Yang, Ting-Yu Cao, Hai-Ying Dang, Zhuo-Chen Han, Jia-Jing Cao, He-Yi Zhang, Ting Cheng, Sheng-Xiao Zhang, Yue-Hong Huo
Efficacy and safety of bimekizumab in the treatment of psoriatic arthritis: a systematic review and meta-analysis. Expert opinion on drug safety (2024)
Qin-Yi Su, Jing Luo, Xin-Miao Wang, Jing-Kai Di, Yi-Xin Cao, Sheng-Xiao Zhang
Efficacy, safety and the lymphocyte subsets changes of low-dose IL-2 in patients with systemic lupus erythematosus: A systematic review and meta-analysis. Immunity, inflammation and disease 12 (1) (2024)
Qin-Yi Su, Jing Luo, Xin-Miao Wang, Jing-Kai Di, Yi-Xin Cao, Sheng-Xiao Zhang
Efficacy, safety and the lymphocyte subsets changes of low-dose IL-2 in patients with systemic lupus erythematosus: A systematic review and meta-analysis. Immunity, inflammation and disease 12 (1) (2024)
Qin-Yi Su, Jing Luo, Yan Zhang, Qian Li, Zhong-Qing Jiang, Zi-Rong Wen, Yu-Ying Wang, Mo-Ran Shi, Sheng-Xiao Zhang
Efficacy and safety of current therapies for difficult-to-treat rheumatoid arthritis: a systematic review and network meta-analysis. Journal of translational medicine 22 (1) (2024)
Qin-Yi Su, Hao-Nan Zhou, Guo-Mei Xia, Rui-Yuan Zhang, Hong-Yuan Tian, Chang Su, Yu-Xin Liu, He-Yi Zhang, Ting Cheng, Yue-Hong Huo, Qian Li, Sheng-Xiao Zhang
Efficacy and Safety of Risankizumab in Patients with Psoriatic Arthritis: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Rheumatology and therapy 11 (2) (2024)
Qin-Yi Su, Hao-Nan Zhou, Guo-Mei Xia, Rui-Yuan Zhang, Hong-Yuan Tian, Chang Su, Yu-Xin Liu, He-Yi Zhang, Ting Cheng, Yue-Hong Huo, Qian Li, Sheng-Xiao Zhang
Efficacy and Safety of Risankizumab in Patients with Psoriatic Arthritis: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Rheumatology and therapy 11 (2) (2024)
Qin-Yi Su, Hao-Nan Zhou, Guo-Mei Xia, Rui-Yuan Zhang, Hong-Yuan Tian, Chang Su, Yu-Xin Liu, He-Yi Zhang, Ting Cheng, Yue-Hong Huo, Qian Li, Sheng-Xiao Zhang
Efficacy and Safety of Risankizumab in Patients with Psoriatic Arthritis: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Rheumatology and therapy (2024)
Qin-Yi Su, Liu Yang, Ting-Yu Cao, Hai-Ying Dang, Zhuo-Chen Han, Jia-Jing Cao, He-Yi Zhang, Ting Cheng, Sheng-Xiao Zhang, Yue-Hong Huo
Efficacy and safety of bimekizumab in the treatment of psoriatic arthritis: a systematic review and meta-analysis. Expert opinion on drug safety (2024)
Yujia Xi, Xinyu Yin, Jing Zhou, Ruotong Shen, Likun Qi, Sheng-Xiao Zhang
Genetically predicted cardiovascular diseases could increase the risk of erectile dysfunction: a bidirectional Mendelian randomization. World journal of urology (2023)
Qinyi Su, Xinmiao Wang, Yongzhi Li, Jiexiang Zhang, Cairui Bai, Xuechun Wang, Liu Yang, Jingting Zhang, Sheng-Xiao Zhang
Efficacy, Safety and the Lymphocyte Subset Changes of Low-Dose IL-2 in Patients with Autoimmune Rheumatic Diseases: A Systematic Review and Meta-Analysis. Rheumatology and therapy (2023)
Yao-Chen Zhang, Ke-Yi Fan, Qi Wang, Jing-Xi Hu, Qian Wang, He-Yi Zhang, Shan Song, Rong Zhao, Jun Qiao, Sheng-Xiao Zhang
Genetically Determined Levels of mTOR-Dependent Circulating Proteins and Risk of Multiple Sclerosis. Neurology and therapy (2023)
Ting Cheng, Huiwen Zhi, Yunxiao Liu, Sheng-Xiao Zhang, Ziyi Song, Ya-Feng Li
Dual Anti-Glomerular Basement Membrane and Anti-Neutrophil Cytoplasmic Antibodies-Positive Rapidly Progressive Glomerulonephritis with Rheumatoid Arthritis and Sjogren's Syndrome: A Case Report and Literature Review. Journal of clinical medicine 11 (22) (2022)
Na-Lin Lai, Sheng-Xiao Zhang, Jia Wang, Jia-Qian Zhang, Cai-Hong Wang, Chong Gao, Xiao-Feng Li
The Proportion of Regulatory T Cells in Patients with Ankylosing Spondylitis: A Meta-Analysis. Journal of immunology research 2019 (2019)
Sheng-Xiao Zhang, Jia Wang, He-Hua Sun, Jia-Qian Zhang, Guang-Ying Liu, Jing Luo, Pei-Feng He, Xiao-Feng Li
Circulating regulatory T cells were absolutely decreased in dermatomyositis/polymyositis patients and restored by low-dose IL-2. Annals of the rheumatic diseases (2019)
Sheng-Xiao Zhang, Jia Wang, Jun-Wei Chen, Ming-Xing Zhang, Yi-Fan Zhang, Fang-Yuan Hu, Zhi-Qin Lv, Chong Gao, Ya-Feng Li, Xiao-Feng Li
The level of peripheral regulatory T cells is linked to changes in gut commensal microflora in patients with systemic lupus erythematosus. Annals of the rheumatic diseases 80 (11) (2019)
Hong-Yan Wen, Jia Wang, Sheng-Xiao Zhang, Jing Luo, Xiang-Cong Zhao, Chen Zhang, Cai-Hong Wang, Fang-Yuan Hu, Xiao-Juan Zheng, Ting Cheng, Hong-Qing Niu, Guang-Ying Liu, Wen-Xian Yang, Na-Na Yu, Jin-Li Ru, Qi-Xiang Chen, Xue-Chun Lu, Pei-Feng He, Chong Gao, Xiao-Feng Li
Low-Dose Sirolimus Immunoregulation Therapy in Patients with Active Rheumatoid Arthritis: A 24-Week Follow-Up of the Randomized, Open-Label, Parallel-Controlled Trial. Journal of immunology research 2019 (2019)